Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
1,225
mentions
- News 843
- X 298
- Blogs 44
- Facebook 16
- +3 more
A Michael Lincoff
PubHawk tracks social media discussions for 8 articles by authors named A Michael Lincoff.
Mentions
3,460
Peak: 112 in Nov 2020
across 8 tracked articles
Extended reach
21,776,156
potential audience
Total likes
29,363
Video views
1,246,079
Mentions per month
Jul 2018 – Jan 2026Where it's discussed
-
News1,946 articles
-
X / Twitter1,223 posts
-
Blogs103 articles
-
Facebook99 posts
-
YouTube48 videos
-
Reddit23 posts
-
Bluesky11 posts
-
Instagram7 posts
Tracked by PubHawk
Most discussed articles
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
600
mentions
- News 360
- X 213
- Facebook 12
- Blogs 8
- +3 more
Cardiovascular Safety of Testosterone-Replacement Therapy.
491
mentions
- News 239
- X 220
- YouTube 15
- Blogs 10
- +3 more
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.
474
mentions
- News 382
- X 64
- Blogs 20
- YouTube 5
- +2 more
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
323
mentions
- X 220
- News 68
- Facebook 15
- Blogs 15
- +2 more
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT Trial.
218
mentions
- X 131
- Facebook 50
- Reddit 13
- News 11
- +4 more
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance.
66
mentions
- News 32
- X 30
- YouTube 2
- Blogs 2
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
63
mentions
- X 47
- News 11
- YouTube 2
- Blogs 2
- +1 more
From PubMed
All publications
Searching PubMed…